Human medicines European public assessment report (EPAR): Replagal, agalsidase alfa, Date of authorisation: 03/08/2001, Revision: 30, Status: Authorised

Human medicines European public assessment report (EPAR): Pregabalin Viatris (previously Pregabalin Mylan), pregabalin, Date of authorisation: 24/06/2015, Revision: 23, Status: Authorised

Human medicines European public assessment report (EPAR): Tuzulby, methylphenidate hydrochloride, Date of authorisation: 28/02/2025, Revision: 2, Status: Authorised

Human medicines European public assessment report (EPAR): Leflunomide medac, leflunomide, Date of authorisation: 27/07/2010, Revision: 25, Status: Authorised

PSUSA/00002688/202503

PSUSA/00002656/202502

Emer Cooke, EMA’s Executive Director: 2025 achievements in medicine regulation

EMA Management Board: highlights of December 2025 meeting

EMA business hours over holiday period

Human medicines European public assessment report (EPAR): Yargesa, miglustat, Date of authorisation: 22/03/2017, Revision: 7, Status: Authorised